Michael A. Kelly

Michael A. Kelly is the Founder and President of Sentry Hill Partners, LLC, a global consulting firm in life sciences transformation and management. Currently serving as Independent Director and Audit Committee Chair for multiple biotechnology and healthcare companies, including nChroma Bio, Prime Medicine, Amicus Therapeutics, DMC Global Inc., and NeoGenomics Laboratories, Michael A. Kelly provides executive counsel and strategic guidance. Previous roles include Senior Vice President of Global Business Services at Amgen and Chief Financial Officer at Tanox, Inc. Michael A. Kelly holds a Bachelor of Science degree in Business Administration with a concentration in Finance and Industrial Relations from Florida Agricultural and Mechanical University.